In AAA, LEF1 may promote pro‐inflammatory T‐cell polarisation (e.g., Th1/Th17) through transcriptional activation of cytokine genes (e.g., IFN‐γ, IL‐17) and modulation of T‐cell receptor signalling. Here, IL17A is linked to triple-A syndrome.